Original Research

Published on 16 Mar 2023

Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D

in Gastrointestinal and Hepatic Pharmacology

Yaoyao Lu
Yuna Chai
Jianli Qiu
Jingmin Zhang
Menglin Wu
Zhe Fu
Yongfu Wang
Chongzhen Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1062630

2,252 views
1 citation

Systematic Review

Published on 16 Mar 2023

Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Huizhu Guo
Ruiqiu Zhang
Pei Zhang
Zhaoyang Chen
Yuqing Hua
Xin Huang
Xiao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1129948

15,174 views
10 citations

Review

Published on 16 Mar 2023

Emerging mechanistic insights of selective autophagy in hepatic diseases

in Gastrointestinal and Hepatic Pharmacology

Abdul Alim Al-Bari
Yuko Ito
Paul G. Thomes
Manoj B. Menon
Marina García-Macia
Raouf Fadel
Alfreda Stadlin
Nicholas Peake
MoezAlIslam Ezzat Faris
Nabil Eid

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149809

6,559 views
14 citations

Editorial

Published on 15 Mar 2023

Editorial: Ulcerative colitis disease therapy: Unveiling the molecular mechanisms of well-defined composition from natural plants

in Gastrointestinal and Hepatic Pharmacology

Yi Tao
Kunming Qin
Huan Li
Lihong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172160

946 views

Clinical Trial

Published on 14 Mar 2023

The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial

in Gastrointestinal and Hepatic Pharmacology

Amal Ahmed Mohamed
Ahmed Abdel Halim
Sahar Mohamed
Seham Mohamed Mahmoud
Eman Mohamed Bahgat Eldemiry
Rasha Sobh Mohamed
Mahmoud Maamoun Shaheen
Gina G. Naguib
Nashwa M. Muharram
Mona G. Khalil

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149967

2,399 views
2 citations

Original Research

Published on 13 Mar 2023

Incidence, clinical features and risk factors of tacrolimus induced idiosyncratic liver injury in renal transplant recipients: A nested case-control study

in Gastrointestinal and Hepatic Pharmacology

Binbin Lv
Longshan Liu
Xiaoman Liu
Min Huang
Xiao Chen
Kejing Tang
Changxi Wang
Pan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1126765

3,973 views
2 citations

Systematic Review

Published on 13 Mar 2023

Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Yunpeng Gu
Lei Sun
Wei Zhang
Tingting Kong
Run Zhou
Yining He
Chaohua Deng
Luping Yang
Jianing Kong
Yutong Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102792

9,316 views
20 citations

Mini Review

Published on 08 Mar 2023

The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease

in Gastrointestinal and Hepatic Pharmacology

Xiangyun Tan
Xinyu Huang
Zhuhang Lu
Liang Chen
Junjie Hu
Xianxiang Tian
Zhenpeng Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124003

2,919 views
4 citations

Review

Published on 03 Mar 2023

Potential of natural flavonols and flavanones in the treatment of ulcerative colitis

in Gastrointestinal and Hepatic Pharmacology

Cailan Li
Ying Tang
Yonghao Ye
Manhua Zuo
Qiang Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1120616

3,279 views
6 citations

Review

Published on 02 Mar 2023

Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming

in Gastrointestinal and Hepatic Pharmacology

Hao Chen
Lan-Lan Li
Yan Du

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1115226

3,532 views
6 citations

Systematic Review

Published on 28 Feb 2023

Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials

in Gastrointestinal and Hepatic Pharmacology

Kun He
Yabing Wang
Jianing Li
Xiaoyin Bai
Zihan Yang
Xianlin Han
Dong Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1131974

2,043 views
2 citations

Original Research

Published on 23 Feb 2023

The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator

in Gastrointestinal and Hepatic Pharmacology

Varsha D. Shiragannavar
Nirmala G. Sannappa Gowda
Lakshana D. Puttahanumantharayappa
Shreyas H. Karunakara
Smitha Bhat
Shashanka K. Prasad
Divya P. Kumar
Prasanna K. Santhekadur

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1135952

5,355 views
21 citations

Editorial

Published on 21 Feb 2023

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation

in Gastrointestinal and Hepatic Pharmacology

Sinéad C. Corr
Gabriella Aviello

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1147936

1,196 views

Original Research

Published on 20 Feb 2023

Brucea javanica oil alleviates intestinal mucosal injury induced by chemotherapeutic agent 5-fluorouracil in mice

in Gastrointestinal and Hepatic Pharmacology

Xinghan Zheng
Liting Mai
Ying Xu
Minghui Wu
Li Chen
Baoyi Chen
Ziren Su
Jiannan Chen
Hongying Chen
Zhengquan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136076

2,553 views
3 citations

Original Research

Published on 17 Feb 2023

UHPLC-MS profiles and antidiarrheal activity of Quercus coccinea münchh. and Quercus robur L. employing in vivo technique

in Gastrointestinal and Hepatic Pharmacology

Mohamed S. Mady
Reham R. Ibrahim
Elsayed K. El-Sayed
Mohamed El-Shazly
Lo-Yun Chen
Kuei-Hung Lai
Fatheya S. El Shaarawy
Fatma A. Moharram

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1120146

2,235 views
3 citations

Original Research

Published on 16 Feb 2023

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury

in Gastrointestinal and Hepatic Pharmacology

Yu-Ting Xiong
Jian-Fei Wang
Xiao-Xia Niu
Yi-Ming Fu
Ke-Xin Wang
Chun-Yan Wang
Qian-Qian Li
Jian-Jun Wang
Jun Zhao
Dong Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1071709

1,788 views
4 citations

Navigation group

Articles

Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D

Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis

Emerging mechanistic insights of selective autophagy in hepatic diseases

Editorial: Ulcerative colitis disease therapy: Unveiling the molecular mechanisms of well-defined composition from natural plants

The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial

Incidence, clinical features and risk factors of tacrolimus induced idiosyncratic liver injury in renal transplant recipients: A nested case-control study

Comparative efficacy of 5 sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor and 4 glucagon-like peptide-1 (GLP-1) receptor agonist drugs in non-alcoholic fatty liver disease: A GRADE-assessed systematic review and network meta-analysis of randomized controlled trials

The essential effect of mTORC1-dependent lipophagy in non-alcoholic fatty liver disease

Potential of natural flavonols and flavanones in the treatment of ulcerative colitis

Krüppel-like factor 15 in liver diseases: Insights into metabolic reprogramming

Neostigmine for non-mild acute pancreatitis: A systematic review and meta-analysis of randomized controlled trials

The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation

Brucea javanica oil alleviates intestinal mucosal injury induced by chemotherapeutic agent 5-fluorouracil in mice

UHPLC-MS profiles and antidiarrheal activity of Quercus coccinea münchh. and Quercus robur L. employing in vivo technique

Autoimmunity associates with severity of illness in elderly patients with drug-induced liver injury